+1 347 708 0418
Biosimilars Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Biosimilars Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Recombinant Non Glycosylated Proteins
Recombinant Glycosylated Proteins
Recombinant Peptides
Segment by Application
Oncology
Chronic and Autoimmune Disease
Blood Disorders
Growth Hormone Disease
Infectious Disease
By Company
Bayer
Eli Lily, Inc.
Pfizer, Inc.
Sandoz International GmbH
Teva Pharmaceutical Industries Limited
Amgen Inc.
Biocon
Dr. Reddys Laboratories
Roche Ltd.
Celltrion, Inc.
Samsung Bioepis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilars Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Recombinant Non Glycosylated Proteins
1.2.3 Recombinant Glycosylated Proteins
1.2.4 Recombinant Peptides
1.3 Market by Application
1.3.1 Global Biosimilars Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Chronic and Autoimmune Disease
1.3.4 Blood Disorders
1.3.5 Growth Hormone Disease
1.3.6 Infectious Disease
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosimilars Treatment Market Perspective (2017-2028)
2.2 Biosimilars Treatment Growth Trends by Region
2.2.1 Biosimilars Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biosimilars Treatment Historic Market Size by Region (2017-2022)
2.2.3 Biosimilars Treatment Forecasted Market Size by Region (2023-2028)
2.3 Biosimilars Treatment Market Dynamics
2.3.1 Biosimilars Treatment Industry Trends
2.3.2 Biosimilars Treatment Market Drivers
2.3.3 Biosimilars Treatment Market Challenges
2.3.4 Biosimilars Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilars Treatment Players by Revenue
3.1.1 Global Top Biosimilars Treatment Players by Revenue (2017-2022)
3.1.2 Global Biosimilars Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Biosimilars Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosimilars Treatment Revenue
3.4 Global Biosimilars Treatment Market Concentration Ratio
3.4.1 Global Biosimilars Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilars Treatment Revenue in 2021
3.5 Biosimilars Treatment Key Players Head office and Area Served
3.6 Key Players Biosimilars Treatment Product Solution and Service
3.7 Date of Enter into Biosimilars Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilars Treatment Breakdown Data by Type
4.1 Global Biosimilars Treatment Historic Market Size by Type (2017-2022)
4.2 Global Biosimilars Treatment Forecasted Market Size by Type (2023-2028)
5 Biosimilars Treatment Breakdown Data by Application
5.1 Global Biosimilars Treatment Historic Market Size by Application (2017-2022)
5.2 Global Biosimilars Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biosimilars Treatment Market Size (2017-2028)
6.2 North America Biosimilars Treatment Market Size by Type
6.2.1 North America Biosimilars Treatment Market Size by Type (2017-2022)
6.2.2 North America Biosimilars Treatment Market Size by Type (2023-2028)
6.2.3 North America Biosimilars Treatment Market Share by Type (2017-2028)
6.3 North America Biosimilars Treatment Market Size by Application
6.3.1 North America Biosimilars Treatment Market Size by Application (2017-2022)
6.3.2 North America Biosimilars Treatment Market Size by Application (2023-2028)
6.3.3 North America Biosimilars Treatment Market Share by Application (2017-2028)
6.4 North America Biosimilars Treatment Market Size by Country
6.4.1 North America Biosimilars Treatment Market Size by Country (2017-2022)
6.4.2 North America Biosimilars Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Biosimilars Treatment Market Size (2017-2028)
7.2 Europe Biosimilars Treatment Market Size by Type
7.2.1 Europe Biosimilars Treatment Market Size by Type (2017-2022)
7.2.2 Europe Biosimilars Treatment Market Size by Type (2023-2028)
7.2.3 Europe Biosimilars Treatment Market Share by Type (2017-2028)
7.3 Europe Biosimilars Treatment Market Size by Application
7.3.1 Europe Biosimilars Treatment Market Size by Application (2017-2022)
7.3.2 Europe Biosimilars Treatment Market Size by Application (2023-2028)
7.3.3 Europe Biosimilars Treatment Market Share by Application (2017-2028)
7.4 Europe Biosimilars Treatment Market Size by Country
7.4.1 Europe Biosimilars Treatment Market Size by Country (2017-2022)
7.4.2 Europe Biosimilars Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilars Treatment Market Size (2017-2028)
8.2 Asia-Pacific Biosimilars Treatment Market Size by Type
8.2.1 Asia-Pacific Biosimilars Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biosimilars Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biosimilars Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Biosimilars Treatment Market Size by Application
8.3.1 Asia-Pacific Biosimilars Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biosimilars Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biosimilars Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Biosimilars Treatment Market Size by Region
8.4.1 Asia-Pacific Biosimilars Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biosimilars Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biosimilars Treatment Market Size (2017-2028)
9.2 Latin America Biosimilars Treatment Market Size by Type
9.2.1 Latin America Biosimilars Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Biosimilars Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Biosimilars Treatment Market Share by Type (2017-2028)
9.3 Latin America Biosimilars Treatment Market Size by Application
9.3.1 Latin America Biosimilars Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Biosimilars Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Biosimilars Treatment Market Share by Application (2017-2028)
9.4 Latin America Biosimilars Treatment Market Size by Country
9.4.1 Latin America Biosimilars Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Biosimilars Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilars Treatment Market Size (2017-2028)
10.2 Middle East & Africa Biosimilars Treatment Market Size by Type
10.2.1 Middle East & Africa Biosimilars Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biosimilars Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biosimilars Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Biosimilars Treatment Market Size by Application
10.3.1 Middle East & Africa Biosimilars Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biosimilars Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biosimilars Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Biosimilars Treatment Market Size by Country
10.4.1 Middle East & Africa Biosimilars Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biosimilars Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Biosimilars Treatment Introduction
11.1.4 Bayer Revenue in Biosimilars Treatment Business (2017-2022)
11.1.5 Bayer Recent Developments
11.2 Eli Lily, Inc.
11.2.1 Eli Lily, Inc. Company Details
11.2.2 Eli Lily, Inc. Business Overview
11.2.3 Eli Lily, Inc. Biosimilars Treatment Introduction
11.2.4 Eli Lily, Inc. Revenue in Biosimilars Treatment Business (2017-2022)
11.2.5 Eli Lily, Inc. Recent Developments
11.3 Pfizer, Inc.
11.3.1 Pfizer, Inc. Company Details
11.3.2 Pfizer, Inc. Business Overview
11.3.3 Pfizer, Inc. Biosimilars Treatment Introduction
11.3.4 Pfizer, Inc. Revenue in Biosimilars Treatment Business (2017-2022)
11.3.5 Pfizer, Inc. Recent Developments
11.4 Sandoz International GmbH
11.4.1 Sandoz International GmbH Company Details
11.4.2 Sandoz International GmbH Business Overview
11.4.3 Sandoz International GmbH Biosimilars Treatment Introduction
11.4.4 Sandoz International GmbH Revenue in Biosimilars Treatment Business (2017-2022)
11.4.5 Sandoz International GmbH Recent Developments
11.5 Teva Pharmaceutical Industries Limited
11.5.1 Teva Pharmaceutical Industries Limited Company Details
11.5.2 Teva Pharmaceutical Industries Limited Business Overview
11.5.3 Teva Pharmaceutical Industries Limited Biosimilars Treatment Introduction
11.5.4 Teva Pharmaceutical Industries Limited Revenue in Biosimilars Treatment Business (2017-2022)
11.5.5 Teva Pharmaceutical Industries Limited Recent Developments
11.6 Amgen Inc.
11.6.1 Amgen Inc. Company Details
11.6.2 Amgen Inc. Business Overview
11.6.3 Amgen Inc. Biosimilars Treatment Introduction
11.6.4 Amgen Inc. Revenue in Biosimilars Treatment Business (2017-2022)
11.6.5 Amgen Inc. Recent Developments
11.7 Biocon
11.7.1 Biocon Company Details
11.7.2 Biocon Business Overview
11.7.3 Biocon Biosimilars Treatment Introduction
11.7.4 Biocon Revenue in Biosimilars Treatment Business (2017-2022)
11.7.5 Biocon Recent Developments
11.8 Dr. Reddys Laboratories
11.8.1 Dr. Reddys Laboratories Company Details
11.8.2 Dr. Reddys Laboratories Business Overview
11.8.3 Dr. Reddys Laboratories Biosimilars Treatment Introduction
11.8.4 Dr. Reddys Laboratories Revenue in Biosimilars Treatment Business (2017-2022)
11.8.5 Dr. Reddys Laboratories Recent Developments
11.9 Roche Ltd.
11.9.1 Roche Ltd. Company Details
11.9.2 Roche Ltd. Business Overview
11.9.3 Roche Ltd. Biosimilars Treatment Introduction
11.9.4 Roche Ltd. Revenue in Biosimilars Treatment Business (2017-2022)
11.9.5 Roche Ltd. Recent Developments
11.10 Celltrion, Inc.
11.10.1 Celltrion, Inc. Company Details
11.10.2 Celltrion, Inc. Business Overview
11.10.3 Celltrion, Inc. Biosimilars Treatment Introduction
11.10.4 Celltrion, Inc. Revenue in Biosimilars Treatment Business (2017-2022)
11.10.5 Celltrion, Inc. Recent Developments
11.11 Samsung Bioepis
11.11.1 Samsung Bioepis Company Details
11.11.2 Samsung Bioepis Business Overview
11.11.3 Samsung Bioepis Biosimilars Treatment Introduction
11.11.4 Samsung Bioepis Revenue in Biosimilars Treatment Business (2017-2022)
11.11.5 Samsung Bioepis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biosimilars Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Recombinant Non Glycosylated Proteins
Table 3. Key Players of Recombinant Glycosylated Proteins
Table 4. Key Players of Recombinant Peptides
Table 5. Global Biosimilars Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Biosimilars Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Biosimilars Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Biosimilars Treatment Market Share by Region (2017-2022)
Table 9. Global Biosimilars Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Biosimilars Treatment Market Share by Region (2023-2028)
Table 11. Biosimilars Treatment Market Trends
Table 12. Biosimilars Treatment Market Drivers
Table 13. Biosimilars Treatment Market Challenges
Table 14. Biosimilars Treatment Market Restraints
Table 15. Global Biosimilars Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Biosimilars Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Biosimilars Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars Treatment as of 2021)
Table 18. Ranking of Global Top Biosimilars Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Biosimilars Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biosimilars Treatment Product Solution and Service
Table 22. Date of Enter into Biosimilars Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biosimilars Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Biosimilars Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Biosimilars Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Biosimilars Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Biosimilars Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Biosimilars Treatment Revenue Share by Application (2017-2022)
Table 30. Global Biosimilars Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Biosimilars Treatment Revenue Share by Application (2023-2028)
Table 32. North America Biosimilars Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Biosimilars Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Biosimilars Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Biosimilars Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Biosimilars Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Biosimilars Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Biosimilars Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Biosimilars Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Biosimilars Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Biosimilars Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Biosimilars Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Biosimilars Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Biosimilars Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Biosimilars Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Biosimilars Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Biosimilars Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Biosimilars Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Biosimilars Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Biosimilars Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Biosimilars Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Biosimilars Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Biosimilars Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Biosimilars Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Biosimilars Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Biosimilars Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Biosimilars Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Biosimilars Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Biosimilars Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Biosimilars Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Biosimilars Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. Bayer Company Details
Table 63. Bayer Business Overview
Table 64. Bayer Biosimilars Treatment Product
Table 65. Bayer Revenue in Biosimilars Treatment Business (2017-2022) & (US$ Million)
Table 66. Bayer Recent Developments
Table 67. Eli Lily, Inc. Company Details
Table 68. Eli Lily, Inc. Business Overview
Table 69. Eli Lily, Inc. Biosimilars Treatment Product
Table 70. Eli Lily, Inc. Revenue in Biosimilars Treatment Business (2017-2022) & (US$ Million)
Table 71. Eli Lily, Inc. Recent Developments
Table 72. Pfizer, Inc. Company Details
Table 73. Pfizer, Inc. Business Overview
Table 74. Pfizer, Inc. Biosimilars Treatment Product
Table 75. Pfizer, Inc. Revenue in Biosimilars Treatment Business (2017-2022) & (US$ Million)
Table 76. Pfizer, Inc. Recent Developments
Table 77. Sandoz International GmbH Company Details
Table 78. Sandoz International GmbH Business Overview
Table 79. Sandoz International GmbH Biosimilars Treatment Product
Table 80. Sandoz International GmbH Revenue in Biosimilars Treatment Business (2017-2022) & (US$ Million)
Table 81. Sandoz International GmbH Recent Developments
Table 82. Teva Pharmaceutical Industries Limited Company Details
Table 83. Teva Pharmaceutical Industries Limited Business Overview
Table 84. Teva Pharmaceutical Industries Limited Biosimilars Treatment Product
Table 85. Teva Pharmaceutical Industries Limited Revenue in Biosimilars Treatment Business (2017-2022) & (US$ Million)
Table 86. Teva Pharmaceutical Industries Limited Recent Developments
Table 87. Amgen Inc. Company Details
Table 88. Amgen Inc. Business Overview
Table 89. Amgen Inc. Biosimilars Treatment Product
Table 90. Amgen Inc. Revenue in Biosimilars Treatment Business (2017-2022) & (US$ Million)
Table 91. Amgen Inc. Recent Developments
Table 92. Biocon Company Details
Table 93. Biocon Business Overview
Table 94. Biocon Biosimilars Treatment Product
Table 95. Biocon Revenue in Biosimilars Treatment Business (2017-2022) & (US$ Million)
Table 96. Biocon Recent Developments
Table 97. Dr. Reddys Laboratories Company Details
Table 98. Dr. Reddys Laboratories Business Overview
Table 99. Dr. Reddys Laboratories Biosimilars Treatment Product
Table 100. Dr. Reddys Laboratories Revenue in Biosimilars Treatment Business (2017-2022) & (US$ Million)
Table 101. Dr. Reddys Laboratories Recent Developments
Table 102. Roche Ltd. Company Details
Table 103. Roche Ltd. Business Overview
Table 104. Roche Ltd. Biosimilars Treatment Product
Table 105. Roche Ltd. Revenue in Biosimilars Treatment Business (2017-2022) & (US$ Million)
Table 106. Roche Ltd. Recent Developments
Table 107. Celltrion, Inc. Company Details
Table 108. Celltrion, Inc. Business Overview
Table 109. Celltrion, Inc. Biosimilars Treatment Product
Table 110. Celltrion, Inc. Revenue in Biosimilars Treatment Business (2017-2022) & (US$ Million)
Table 111. Celltrion, Inc. Recent Developments
Table 112. Samsung Bioepis Company Details
Table 113. Samsung Bioepis Business Overview
Table 114. Samsung Bioepis Biosimilars Treatment Product
Table 115. Samsung Bioepis Revenue in Biosimilars Treatment Business (2017-2022) & (US$ Million)
Table 116. Samsung Bioepis Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosimilars Treatment Market Share by Type: 2021 VS 2028
Figure 2. Recombinant Non Glycosylated Proteins Features
Figure 3. Recombinant Glycosylated Proteins Features
Figure 4. Recombinant Peptides Features
Figure 5. Global Biosimilars Treatment Market Share by Application: 2021 VS 2028
Figure 6. Oncology Case Studies
Figure 7. Chronic and Autoimmune Disease Case Studies
Figure 8. Blood Disorders Case Studies
Figure 9. Growth Hormone Disease Case Studies
Figure 10. Infectious Disease Case Studies
Figure 11. Biosimilars Treatment Report Years Considered
Figure 12. Global Biosimilars Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Biosimilars Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Biosimilars Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Biosimilars Treatment Market Share by Players in 2021
Figure 16. Global Top Biosimilars Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Biosimilars Treatment Revenue in 2021
Figure 18. North America Biosimilars Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Biosimilars Treatment Market Size Market Share by Type (2017-2028)
Figure 20. North America Biosimilars Treatment Market Size Market Share by Application (2017-2028)
Figure 21. North America Biosimilars Treatment Market Size Share by Country (2017-2028)
Figure 22. United States Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Biosimilars Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Biosimilars Treatment Market Size Market Share by Type (2017-2028)
Figure 26. Europe Biosimilars Treatment Market Size Market Share by Application (2017-2028)
Figure 27. Europe Biosimilars Treatment Market Size Share by Country (2017-2028)
Figure 28. Germany Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Biosimilars Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Biosimilars Treatment Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Biosimilars Treatment Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Biosimilars Treatment Market Size Share by Region (2017-2028)
Figure 38. China Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Biosimilars Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Biosimilars Treatment Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Biosimilars Treatment Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Biosimilars Treatment Market Size Share by Country (2017-2028)
Figure 48. Mexico Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Biosimilars Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Biosimilars Treatment Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Biosimilars Treatment Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Biosimilars Treatment Market Size Share by Country (2017-2028)
Figure 54. Turkey Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Biosimilars Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Bayer Revenue Growth Rate in Biosimilars Treatment Business (2017-2022)
Figure 58. Eli Lily, Inc. Revenue Growth Rate in Biosimilars Treatment Business (2017-2022)
Figure 59. Pfizer, Inc. Revenue Growth Rate in Biosimilars Treatment Business (2017-2022)
Figure 60. Sandoz International GmbH Revenue Growth Rate in Biosimilars Treatment Business (2017-2022)
Figure 61. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Biosimilars Treatment Business (2017-2022)
Figure 62. Amgen Inc. Revenue Growth Rate in Biosimilars Treatment Business (2017-2022)
Figure 63. Biocon Revenue Growth Rate in Biosimilars Treatment Business (2017-2022)
Figure 64. Dr. Reddys Laboratories Revenue Growth Rate in Biosimilars Treatment Business (2017-2022)
Figure 65. Roche Ltd. Revenue Growth Rate in Biosimilars Treatment Business (2017-2022)
Figure 66. Celltrion, Inc. Revenue Growth Rate in Biosimilars Treatment Business (2017-2022)
Figure 67. Samsung Bioepis Revenue Growth Rate in Biosimilars Treatment Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Buy
